WuXi lands a lead role in Genomics England's big project

Chinese CRO WuXi PharmaTech is on board to help Genomics England pore over samples in its massive project to sequence the genomes of 100,000 Britons.

Fast-growing Charles River trades $36M for a drug discovery outfit

Charles River Laboratories, on the heels of some M&A-driven revenue growth, acquired another early-stage research company, paying $36 million for a German provider of drug discovery services.

Parexel touts its IT-enabled R&D services amid company shakeup

Parexel International, in the midst of sweeping cost cuts, said it has further integrated technology into its drug development services, creating a data-informed process designed to speed up timelines and save money.

PRA expands in Singapore with eyes on Asian growth

PRA Health Sciences is moving into a bigger space in Singapore, consolidating its operations there and looking to boost its share of the growing market for clinical research in Asia.

Quintiles lends its data-crunching know-how to Apple's ResearchKit

Quintiles has contributed some open-source code to improve Apple's ResearchKit project, a platform designed to help physicians and scientists gather medical data from millions of patients.

PPD deepens its Japanese focus with new joint venture leadership

PPD hired a general manager to help grow its Japan-focused joint venture with Shin Nippon Biomedical Laboratories, snagging a Parexel International veteran as it works to expand its presence in a growing market for clinical development services.

WuXi and Lilly pair up to develop a cardio drug in China

Eli Lilly is partnering with CRO WuXi PharmaTech to develop a cholesterol-lowering pill in China, relying on local expertise in hopes of tapping a growing market.

CRO BioDuro merges with Formex after a private equity takeout

BioDuro, once a division of PDD, has merged with contract manufacturer Formex, expanding its production capabilities in the U.S. while maintaining its research presence in China.

Quintiles founder stepping down as chairman after 33 years

Quintiles founder Dennis Gillings is set to vacate his chairmanship at the end of 2015, ending a 33-year tenure at the top that saw the North Carolina company grow into the world's biggest CRO.

Evotec posts 50% growth with a big year in sight

German contract researcher Evotec grew its revenue by 50% in the first 9 months of 2015, executing its hybrid model and expanding its list of Big Pharma partners.

Accelovance strikes a nonprofit partnership to reach developing world

CRO Accelovance is pairing up with a nonprofit clinical research outfit to bring its services to the developing world.

Icon eyes Asia growth with a pair of exec appointments

CRO giant Icon is looking to expand its share of the drug development market in Asia, hiring a pair of local veterans to deepen its ties to the region.

Catalent ekes out revenue growth in the face of currency troubles

Catalent ticked up its year-over-year revenue in the company's fiscal first quarter, absorbing a significant hit from foreign exchange fluctuations and setting the pace for a nearly $2 billion year.

PRA narrows its sales guidance on the way to a record year

PRA Health Sciences posted another quarter of revenue growth but is narrowing its full-year sales projection.

Charles River boosts its 2015 outlook after strong sales quarter

Charles River Laboratories returned to revenue growth on a wave of dealmaking, lifting its full-year guidance in response.

WuXi pads its revenue on the way to a big buyout decision

Chinese CRO WuXi PharmaTech extended its run of quarterly growth on the eve of a shareholder vote that could take the company private in a multibillion-dollar deal.

Novartis, Qualcomm back trial startup's $6.5M round

Lux Ventures and a joint venture between Novartis and Qualcomm are investing $6.5 million into Science 37, an upstart company that promises to make clinical trials more efficient by uniting stakeholders.

Parexel's profits slide as it slashes costs

Parexel International, in the process of shedding about 850 jobs, saw its net income dip in the fiscal first quarter, dimming its expectations for the full year.

INC boosts its outlook after another big revenue quarter

INC Research is ticking up its revenue expectations for 2015 after turning in another quarter of sales growth, counting on its expanded operation to keep contracts rolling in.

Icon ekes out another quarter of growth despite currency woes

Irish-headquartered CRO Icon kept its streak of quarterly revenue growth running, posting a 1.8% year-over-year increase in sales.